Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-800
Closed -$176K 15
2026
Q1
$176K Buy
+800
New +$285K 0.01% 134
2025
Q4
Sell
-100
Closed -$28.2K 129
2025
Q3
$28.2K Buy
+100
New +$29K ﹤0.01% 116
2022
Q4
Sell
-5,500
Closed -$1.24M 205
2022
Q3
$1.24M Sell
5,500
-2,100
-28% -$509K 0.1% 165
2022
Q2
$1.85M Sell
7,600
-16,000
-68% -$3.92M 0.13% 104
2022
Q1
$5.71M Buy
+23,600
New +$5.42M 0.22% 98
2021
Q4
Sell
-6,900
Closed -$1.47M 40
2021
Q3
$1.47M Buy
6,900
+2,500
+57% +$575K 0.1% 162
2021
Q2
$1.07M Buy
4,400
+2,900
+193% +$713K 0.11% 100
2021
Q1
$374K Buy
1,500
+800
+114% +$191K 0.03% 75
2020
Q4
$161K Buy
+700
New +$161K 0.01% 75

Other funds holding AMGN

QVR's AMGN Position: Q2 2026 in Review

QVR sold out of Amgen (AMGN) in Q2 2026, closing a stake of 89 shares — an estimated $31.3K sold.

QVR first reported a position in AMGN in Q4 2020 and held it in 6 quarters. The position peaked at $439K in Q3 2022. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • QVR reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • QVR sold 89 Amgen shares in Q2 2026, an estimated $31.3K.
  • QVR first reported a position in Amgen in Q4 2020 and held it in 6 quarters.
  • QVR's Amgen position peaked at $439K in Q3 2022.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.